The Role of Carboxy-Terminal Glycosaminoglycan-binding Domain of Vitronectin in Cytoskeletal Organization and Migration of Endothelial Cells

References

• Honn K V., Tang D G. Adhesion molecules and tumor cell interaction with subendothelium and subendothelial matrix. Cancer and Metastasis Reviews 1992; 11: 353–75
   PubMed Web of Science ®Google Scholar
• Barnes D W., Silnutzer J, See C, Shaffer M. Characterization of human serum spreading factor with monoclonal antibody. Proc Natl Acad Sc USA 1983; 80: 1362–66
   PubMed Web of Science ®Google Scholar
• Hayman E G., Pierschbacher M D., Ohgren Ruoslahti Y. E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sc USA 1983; 80: 4003–7
   PubMed Web of Science ®Google Scholar
• Suzuki S, Oldberg A, Hayman E G., Pierschbacher M D., Ruoslahti E. Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J 1985; 4: 2519–24
   PubMed Web of Science ®Google Scholar
• Jenne D, Stanley K K. Molecular cloning of S-protein, a link between complement, coagulation and cell substrate adhesion. EMBO BO 1985; 4: 391–395
   Web of Science ®Google Scholar
• Pytela R., Pierschbacher M D., Ginsberg M H., Plow E F., Ruoslahti E. Platelet membrane protein IIB-IIIa: Member of a family of Arg-Gly-Asp-specific adhesion receptors. Science 1986; 231: 1559–1561
   PubMed Web of Science ®Google Scholar
• Charo I F., Bekeart L S., Phillips D R. The platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and extracellular matrix. J Biol Chem 1987; 262: 9935–38
   PubMed Web of Science ®Google Scholar
• Bodary S C., McLean J W. The integrin β1 submit associates with the vitronectin receptor αV submit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem, 265: 5938–41
   PubMed Web of Science ®Google Scholar
• Chen C, Thiagarajan S., Schwartz P. SM., Harlan J M., Heimark R L. The platelet glycoprotein IIb/IIIa-like protein in human endothelial cells promotes adhesion but not initial attachment to extracellular matrix. J Cell Biol 1987; 105: 1885–92
   PubMed Web of Science ®Google Scholar
• Guettier C., Hinglais N., Bruneval P, Kazatchkine M, Bariety J, Camilleri J P. Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries. Virchows Arch 1989; 414: 309–313
   Web of Science ®Google Scholar
• Sato R, Komine Y., Imanka T, Takano T. Monoclonal antibody EMRla/212D recognizing site of deposition of extracellular lipid in atherosclerosis. Isolation and characterization of the cDNA clone for that antigen. J Bio Chem 1990; 265: 21232–6
   PubMed Web of Science ®Google Scholar
• Declerck P J., De Mol M, Alessi M-C, Baudner S, Paques E-P, Preissner K T., Müller-Berghaus G, Collen D. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma: Identification as a multimeric form of S protein (Vitronectin). J Biol Chem 1988; 263: 15454–61
   PubMed Web of Science ®Google Scholar
• Wiman B., Almquist A, Siguardorttir O., Lindahl T. Plasminogen activator inhibitor is bound to vitronectin in plasma. FEBS Lett 1988; 242: 125–8
   PubMed Web of Science ®Google Scholar
• Preissner K T., Müller-Berghaus G. Neutralization and binding of heparin by S-protein/vitronectin in the inhibition of factor Xa by antithrombin III: Involvement of an inducible heparin-binding domain of S protein/vitronectin. J Biol Chem 1987; 262: 12247–53
   PubMed Web of Science ®Google Scholar
• Barnes D W., Reing J E., Amos B. Heparin-binding properties of human serum spreading factor. J Biol Chem 1985; 260: 9117–22
   PubMed Web of Science ®Google Scholar
• Tomasini B, Mosher R. DF. The identity of vitronectin and S protein. Immunological cross reactivity and functional studies. Blood 1987; 68: 737–42
   Web of Science ®Google Scholar
• Kost C, Stuber W, Ehrlich H J., Pannekoek H, Preissner K T. Mapping of binding sites for heparin. plasminogen activator-1 and vitronectin heparin binding domain. J Biol Chem 1992; 267: 12098–105
   PubMed Web of Science ®Google Scholar
• Thronton S C., Mueller S N., Levine E M. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science (Wash.DC) 1983; 227: 680–681
   Google Scholar
• Yatohgo T., Izumi M., Kashiwagi H, Hayashi M. Novel purification of vitronectin from plasma by heparin affinity chromatography. Cell structure and function 1988; 13: 281–292
   PubMed Web of Science ®Google Scholar
• Landon M. Cleavage of aspartyl-prolyl bonds. Methods in Enzymol 1977; 47: 145–47
   PubMedGoogle Scholar
• Suzuki S., Pierschbacher M D., Hayman E, Nguyen G. K., Ohgren Y, Ruoslahti E. Domain structure of vitronectin: Alignment of active sites. J Biol Chem 1984; 259: 15307–14
   PubMed Web of Science ®Google Scholar
• Cherny R C., Honan M A., Thiagarajan P. Site-directed mutagenesis of Arginine-Glycine Aspartic acid in vitronectin abolishes cell adhesion. J Biol Chem, 268: 9725–29
   PubMed Web of Science ®Google Scholar
• Frangioni J V., Neel-Benjamin B G. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Analytical Biochemistry 1993; 210: 179–187
   PubMed Web of Science ®Google Scholar
• VanWinkle W B., Snuggs M., Buja L M. Cytoskeletal alterations in cultured cardiomyocytes following exposure to the lipid peroxidation product, 4-hydroxynonenal. Cell Motil. Cytoskel 1994; 28: 119–134
   PubMed Web of Science ®Google Scholar
• Brown S, Lundgren L. C., Nordt H., Fujii T. S. Stimulation of migration human aortic smooth muscle cells by vitronectin: Implication for atherosclerosis. Cardiovascular Research 1994; 28: 1815–20
   PubMed Web of Science ®Google Scholar
• Gottlieb A I., Langille B, Wong L. Mkk, Kim D W. Biology of disease: Structure and function of the endothelial cytoskeleton. Lab. Invest 1991; 65: 123–137
   PubMed Web of Science ®Google Scholar
• Burridge K, Fath Kelly K., Nuckolls T., Turner G. C. Focal Adhesions. Annu Rev Cell Biol 1988; 4: 487–525
   PubMedGoogle Scholar
• Madri J A., Williams S K. Capillary endothelial cell cultures: Phenotypic modulation by matrix components. J. Cell Biology 1983; 97: 153–165
   PubMed Web of Science ®Google Scholar
• Woods A., Couchman J R., Johansson S., Hook M. Adhesion and cytoskeletal reorganization of fibroblasts in response to fibronectin fragments. EMBO J 1986; 5: 665–70
   PubMed Web of Science ®Google Scholar
• Izzard C S., Radinsky R., Culp L A. Substratum contracts and cytoskeletal reorganization of Balb/c 3T3 cells on a cell-binding fragment and heparin-binding fragments of plasma fibronectin. Exp Cell Res 1986; 165: 320–336
   PubMed Web of Science ®Google Scholar
• Woods A., Hook M., Kjellen L, Smith C, Rees G. DA. Relationship of heparan sulfate proteoglycans to the cytoskeleton and extracellular matrix of cultured fibroblasts. J Cell biol 1984; 99: 1743
   PubMed Web of Science ®Google Scholar
• VanWinkle W. B., Snuugs M., Buja L. M. Hypoxia-induced alterations in cytoskeleton coincide with collagenase and expression in cultured neonatal cardiomyocytes. J. Mol. Cell Cardiol 1995; 27: 2531–2542
   PubMed Web of Science ®Google Scholar
• Wang N., Butler J P., Ingber D E. Mechanotransduction across the cell surface and through the cytoskeleton. Science 1993; 260: 1124–1127
   PubMed Web of Science ®Google Scholar
• Lee G, Johnstone M. B., Jacobson K., Caterson B. The dynamic structure of pericellular matrix on living cells. J Cell Biology 1993; 123: 1899–1907
   PubMed Web of Science ®Google Scholar
• Sockmann A., Hess S., Declerck P, Timpl R., Preissner K T. Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. J Biol Chem 1993; 268: 22874–82
   PubMed Web of Science ®Google Scholar
• Yeo T, Brown K. L., Dvorak H F. Alteration in proteoglycan synthesis common to healing wounds and tumors. Am J Pathol 1999; 138: 1437–50
   Google Scholar